Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
July 25, 2003
Fluticasone propionate aqueous nasal spray improves nasal symptoms of seasonal allergic rhinitis when used as needed (prn)
Mark S Dykewicz, Harold B Kaiser, Robert A Nathan, et al.
Allergy and Asthma Proceedings
|
January 17, 2003
No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year
David B Allen, Eli O Meltzer, Robert F Lemanske, et al.
Allergy and Asthma Proceedings
|
June 5, 2004
Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function
Ketan K Sheth, Cindy K Cook, Edward E Philpot, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
June 29, 2006
Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms
Bruce G Martin, Charles P Andrews, Julius H van Bavel, et al.
Allergy and Asthma Proceedings
|
September 12, 2002
Relief of sinus pain and pressure with fluticasone propionate aqueous nasal spray: a placebo-controlled trial in patients with allergic rhinitis
Paul H Ratner, William C Howland, Robert L Jacobs, et al.
Pediatrics
|
July 3, 2003
Lack of effect of fluticasone propionate aqueous nasal spray on the hypothalamic-pituitary-adrenal axis in 2- and 3-year-old patients
Stanley P Galant, Isaac R Melamed, Anjuli S Nayak, et al.
American Journal of Rhinology & Allergy
|
March 7, 2012
No mucosal atrophy and reduced inflammatory cells: active-controlled trial with yearlong fluticasone furoate nasal spray
Wytske J Fokkens, Bas Rinia, Cornelis M van Drunen, et al.
Allergy and Asthma Proceedings
|
May 26, 2009
Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy
Charles P Andrews, Bruce G Martin, Robert L Jacobs, et al.
The Lancet. Rheumatology
|
January 24, 2024
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements
Anna-Maria Hoffmann-Vold, Toby M Maher, Edward E Philpot, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
July 25, 2003
Fluticasone propionate aqueous nasal spray improves nasal symptoms of seasonal allergic rhinitis when used as needed (prn)
Mark S Dykewicz, Harold B Kaiser, Robert A Nathan, et al.
Allergy and Asthma Proceedings
|
January 17, 2003
No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year
David B Allen, Eli O Meltzer, Robert F Lemanske, et al.
Allergy and Asthma Proceedings
|
June 5, 2004
Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function
Ketan K Sheth, Cindy K Cook, Edward E Philpot, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
June 29, 2006
Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms
Bruce G Martin, Charles P Andrews, Julius H van Bavel, et al.
Allergy and Asthma Proceedings
|
September 12, 2002
Relief of sinus pain and pressure with fluticasone propionate aqueous nasal spray: a placebo-controlled trial in patients with allergic rhinitis
Paul H Ratner, William C Howland, Robert L Jacobs, et al.
Pediatrics
|
July 3, 2003
Lack of effect of fluticasone propionate aqueous nasal spray on the hypothalamic-pituitary-adrenal axis in 2- and 3-year-old patients
Stanley P Galant, Isaac R Melamed, Anjuli S Nayak, et al.
American Journal of Rhinology & Allergy
|
March 7, 2012
No mucosal atrophy and reduced inflammatory cells: active-controlled trial with yearlong fluticasone furoate nasal spray
Wytske J Fokkens, Bas Rinia, Cornelis M van Drunen, et al.
Allergy and Asthma Proceedings
|
May 26, 2009
Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy
Charles P Andrews, Bruce G Martin, Robert L Jacobs, et al.
The Lancet. Rheumatology
|
January 24, 2024
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements
Anna-Maria Hoffmann-Vold, Toby M Maher, Edward E Philpot, et al.
Page
of 3